Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01014767 · ClinicalTrials.gov registry record · Phase 3
Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors
A Phase 3 study, sponsored by Tufts Medical Center.
- Terminated
- Registry status
- Phase 3
- Development phase
- 27
- Enrollment target
NCT01014767 is a Phase 3 study that was terminated before completion, run by Tufts Medical Center. The registered enrollment target is 27 participants.
The verdict
NCT01014767, a Phase 3 study, was terminated before completion, sponsored by Tufts Medical Center.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 27 participants
- Enrollment target
Study Summary
This is a "tissue banking and data review" research study that also has a "clinical" research part: * The goal of the tissue banking part of this study is to store tissue in a research tissue bank by the International Society for Pediatric Oncology (SIOP) at an international reference center for choroid plexus tumors. The tissue will be used in future research related to cancer. * The goal of the data review part of this study is to collect information from the medical records of patients with choroid plexus tumors, and to store the information in SIOP databases for use in future research related to cancer. * The goal of this clinical research study is to compare 4 chemotherapy treatments for choroid plexus tumors. The safety and level of effectiveness of these study treatments will be compared and studied. The study drugs include different combinations of etoposide, carboplatin, vincristine, cyclophosphamide, methotrexate, doxorubicin, cisplatin, dactinomycin, temozolomide, and irinotecan.
Interventions
- DRUG Cyclophosphamide
- DRUG Carboplatin
- DRUG Cisplatin
- DRUG Doxorubicin
- DRUG Dactinomycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2009-11 |
| Est. Completion | 2014-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01014767
The ClinicalTrials.gov registry entry for NCT01014767 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Cyclophosphamide is the first listed.
NCT01014767 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01014767 about?
NCT01014767 is a clinical study titled "Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors". This is a "tissue banking and data review" research study that also has a "clinical" research part: * The goal of the tissue banking part of this study is to store tissue in a research tissue bank by the International Society for Pediatric Oncology (SIOP) at an international reference center for ch...
What is the current status of trial NCT01014767?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 27 participants. The study started on 2009-11. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01014767?
The interventions under investigation include: Cyclophosphamide (DRUG), Carboplatin (DRUG), Cisplatin (DRUG), Doxorubicin (DRUG), Dactinomycin (DRUG).
Who is sponsoring clinical trial NCT01014767?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.